1. Home
  2. MPTI vs MAIA Comparison

MPTI vs MAIA Comparison

Compare MPTI & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo M-tron Industries Inc.

MPTI

M-tron Industries Inc.

HOLD

Current Price

$58.14

Market Cap

150.9M

Sector

N/A

ML Signal

HOLD

Logo MAIA Biotechnology Inc.

MAIA

MAIA Biotechnology Inc.

HOLD

Current Price

$1.63

Market Cap

49.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MPTI
MAIA
Founded
1965
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
150.9M
49.3M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
MPTI
MAIA
Price
$58.14
$1.63
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
37.7K
916.3K
Earning Date
02-25-2026
11-07-2025
Dividend Yield
N/A
N/A
EPS Growth
19.64
N/A
EPS
2.40
N/A
Revenue
$52,989,000.00
N/A
Revenue This Year
$13.32
N/A
Revenue Next Year
$10.56
N/A
P/E Ratio
$24.27
N/A
Revenue Growth
12.79
N/A
52 Week Low
$34.50
$0.87
52 Week High
$61.91
$2.74

Technical Indicators

Market Signals
Indicator
MPTI
MAIA
Relative Strength Index (RSI) 63.98 59.99
Support Level $51.45 $1.48
Resistance Level $55.23 $1.66
Average True Range (ATR) 2.48 0.13
MACD 0.59 0.02
Stochastic Oscillator 88.17 87.74

Price Performance

Historical Comparison
MPTI
MAIA

About MPTI M-tron Industries Inc.

M-Tron Industries Inc is a diversified holding company with subsidiaries engaged in designing, manufacturing, and marketing high-engineered, high-reliability frequency and spectrum control products used to control the frequency or timing of signals in electronic circuits in various applications. The company's serving markets are aerospace and defense, space, and avionics. The company offers products such as microwave and millimeter wave filters; cavity, crystal, ceramic, lumped element, and switched filters; crystal resonators, integrated microwave assemblies, and solid-state power amplifier products.

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.

Share on Social Networks: